SARS-CoV-2 hybrid immunity CDR profiling

downstream-application

SARS-CoV-2 hybrid immunity CDR profiling: downstream-application. LC-MS/MS profiling of complementarity determining regions of anti-RBD antibodies, partly by de novo sequencing, separates hybrid-immunity CDR profiles from…

LC-MS/MS profiling of complementarity determining regions of anti-RBD antibodies, partly by de novo sequencing, separates hybrid-immunity CDR profiles from vaccination-only ones.

Kind downstream-application
Deep learning no
Acquisition DDA
Application area Antibodyomics

Paper describing it

Authors (17)

Glynis Frans, Doreen Dillaerts, Tom Dehaemers, Jan Van Elslande, Jonas De Leeuw, Lise Boon, Wim Maes, Nico Callewaert, Bas Calcoen, Lina Ancheva, Maaike Cockx, Nick Geukens, Kusay Arat, Rita Derua, Pieter Vermeersch, Sebastien Carpentier, Xavier Bossuyt

Seen in the charts

Back to the full map

Back to top